Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance
Further analyses are needed to confirm the early-stage and long-term effectiveness of choline alfoscerate in specific populations, which will help in considering its reimbursement.
Authors
- Jung‐woo Chae (ORCID: https://orcid.org/0000-0001-6026-7063)
- Hwi‐yeol Yun (ORCID: https://orcid.org/0000-0001-8793-2449)
- Khanh Linh Duong (ORCID: https://orcid.org/0000-0002-9578-0083)
- Hye-Kyung Jung (ORCID: https://orcid.org/0009-0003-1246-7994)
- Bo Ram Yang (ORCID: https://orcid.org/0000-0002-8771-8829)
- Sang Ki Lee (ORCID: https://orcid.org/0000-0001-8507-564X)
- Young Jin Moon
- Han Yi Lee
Institutions
- University of Massachusetts Chan Medical School (US)
- Chungnam National University (KR)
Publication Details
- Journal
- BMC Geriatrics
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1186/s12877-024-05531-y
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- National Research Foundation
- Chungnam National University
- Ministry of Environment
- National Health Insurance Service
- Korea Institute of Toxicology
- National Research Foundation of Korea
- Ministry of Education, India
- Ministry of Science and ICT, South Korea
- Korea Environmental Industry and Technology Institute
- Institute for Information and Communications Technology Promotion